Compounds > 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
Page last updated: 2024-09-03

1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Peritoneal Neoplasms

1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid has been researched along with Peritoneal Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blechert, B; Bruchertseifer, F; Essler, M; Gärtner, FC; Morgenstern, A; Neff, F; Seidl, C; Senekowitsch-Schmidtke, R1
Boerman, OC; Corstens, FH; Dijkgraaf, I; Frielink, C; Kruijtzer, JA; Liskamp, RM; Oyen, WJ1

Other Studies

2 other study(ies) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Peritoneal Neoplasms

ArticleYear
Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosis.
    European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:4

    Topics: Actinium; Animals; Bismuth; Cell Line, Tumor; Disease Models, Animal; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Kidney; Mice; Organometallic Compounds; Pentetic Acid; Peptides; Peritoneal Neoplasms; Radioisotopes; Treatment Outcome; Xenograft Model Antitumor Assays

2012
Alpha v beta 3 integrin-targeting of intraperitoneally growing tumors with a radiolabeled RGD peptide.
    International journal of cancer, 2007, Feb-01, Volume: 120, Issue:3

    Topics: Animals; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Delivery Systems; Female; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Injections, Intraperitoneal; Injections, Intravenous; Integrin alphaVbeta3; Mice; Mice, Inbred BALB C; Mice, Nude; Oligopeptides; Ovarian Neoplasms; Peritoneal Neoplasms; Radiopharmaceuticals; Survival Analysis; Tissue Distribution; Xenograft Model Antitumor Assays

2007